| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |